0001209191-20-003753.txt : 20200116 0001209191-20-003753.hdr.sgml : 20200116 20200116180548 ACCESSION NUMBER: 0001209191-20-003753 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200115 FILED AS OF DATE: 20200116 DATE AS OF CHANGE: 20200116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Dea Louis CENTRAL INDEX KEY: 0001521114 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 20531892 MAIL ADDRESS: STREET 1: C/O MPM ACQUISITION CORP. STREET 2: 200 CLARENDON STREET, 54TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-207-0202 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-15 0 0001662524 AKCEA THERAPEUTICS, INC. AKCA 0001521114 O'Dea Louis C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210 0 1 0 0 Chief Medical Officer Common Stock 2020-01-15 4 A 0 28000 0.00 A 48000 D Represents restricted stock unit award granted under the Issuer's 2015 Equity Incentive Plan. /s/ Joshua F. Patterson, Attorney-in-Fact 2020-01-16